Health ❯ Pharmaceuticals ❯ Drug Development ❯ Clinical Trials

Phase 3 Trials

MoonLake Faces Expanding Securities Suits as Lead-Plaintiff Deadline Nears

Investors face a Dec. 15 deadline to seek lead-plaintiff status in cases over alleged misstatements about SLK's efficacy.

aTyr Pharma Lead‑Plaintiff Deadline Hits as Rival Firms Vie to Steer Securities Case